Insulin aspart, recombinant Subcutaneous and Loratadine Tablet
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Loratadine Tablet and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: loratadine
Brand name: Alavert, Claritin, Claritin Reditab, Clear-Atadine, Dimetapp ND, Ohm Allergy Relief, QlearQuil All Day & Night, Tavist ND, Wal-itin
Synonyms: Loratadine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Loratadine-D 12 Hour
- Insulin aspart, recombinant Subcutaneous-Loratadine-D 24 Hour
- Insulin aspart, recombinant Subcutaneous-Lorazepam
- Insulin aspart, recombinant Subcutaneous-Lorazepam Concentrate
- Insulin aspart, recombinant Subcutaneous-Lorazepam injection
- Insulin aspart, recombinant Subcutaneous-Lorazepam Injection Solution
- Loratadine Tablet-Insulin degludec
- Loratadine Tablet-Insulin Degludec (U-100) Prefilled Pens
- Loratadine Tablet-Insulin Degludec (U-100) Vials
- Loratadine Tablet-Insulin Degludec (U-200) Prefilled Pens
- Loratadine Tablet-Insulin degludec and liraglutide
- Loratadine Tablet-Insulin degludec and liraglutide Subcutaneous